- Citations, last 5 years
- 2 537
- Works, last 5 years
- 86
- h-index
- 194
- Scientists listed
- 0
- Grants since 2016
- 6
Grants received
2020–2022 · research · R44
A Clinical Study of Latiglutenase as a Treatment for Type 1 Diabetics with Celiac Disease
David Matthew Maahs · ImmunoGen (United States) · funded by National Institutes of Health
2020–2023 · research · R44
A Clinical Study of Latiglutenase as a Treatment for Type 1 Diabetics with Celiac Disease
David Matthew Maahs · ImmunoGen (United States) · funded by National Institutes of Health
2019–2024 · cooperative agreement · U44
A Clinical Study of Latiglutenase as a Treatment for Symptom Reduction for Celiac Disease
Jack A. Syage · ImmunoGen (United States) · funded by National Institutes of Health
2019–2020 · research · R44
A Clinical Study of Latiglutenase as a Treatment for Type 1 Diabetics with Celiac Disease
David Matthew Maahs · ImmunoGen (United States) · funded by National Institutes of Health
2019 · cooperative agreement · U44
A Clinical Study of Latiglutenase as a Treatment for Symptom Reduction for Celiac Disease
Joseph A Murray · ImmunoGen (United States) · funded by National Institutes of Health
2017–2021 · research · R33
Latiglutenase as a Treatment for Celiac Disease
Joseph A Murray · ImmunoGen (United States) · funded by National Institutes of Health
